title: A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
abstract: The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4+ T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4+ T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies.
authors.affiliation: University of British Columbia Centre for Disease Control, 655 West 12th Ave., Vancouver, BC V5Z 4R4, Canada. robert.brunham@bccdc.ca.
authors.forename: Jose
authors.initials: J
authors.lastname: Rey-Ladino
authors.forename: Kasra M
authors.initials: KM
authors.lastname: Koochesfahani
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Zaharik
authors.forename: Caixia
authors.initials: C
authors.lastname: Shen
authors.forename: Robert C
authors.initials: RC
authors.lastname: Brunham
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D001854:Bone Marrow Cells; D002454:Cell Differentiation / Q000276:immunology*; D002690:Chlamydia Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D002692:Chlamydia trachomatis / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity / Q000528:radiation effects; D003713:Dendritic Cells / Q000166:cytology* / Q000276:immunology / Q000378:metabolism; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D010641:Phenotype; D018410:Pneumonia, Bacterial / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D014466:Ultraviolet Rays; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D001428:Bacterial Vaccines; D000949:Histocompatibility Antigens Class II; D015164:Vaccines, Inactivated; D018799:Intercellular Adhesion Molecule-1
references.citation: J Immunol. 2000 Apr 15;164(8):4212-9
references.pmid: 10754317
references.citation: J Immunol. 1998 Aug 1;161(3):1439-46
references.pmid: 9686609
references.citation: J Infect Dis. 2000 Jun;181 Suppl 3:S538-43
references.pmid: 10839755
references.citation: Mol Med. 2000 Jul;6(7):604-12
references.pmid: 10997341
references.citation: Curr Top Microbiol Immunol. 2000;251:167-71
references.pmid: 11036772
references.citation: Infect Immun. 2000 Dec;68(12):6979-87
references.pmid: 11083822
references.citation: J Exp Med. 2001 Jan 15;193(2):233-8
references.pmid: 11208863
references.citation: Infect Immun. 2001 Jul;69(7):4667-72
references.pmid: 11402013
references.citation: Cell. 2001 Aug 10;106(3):259-62
references.pmid: 11509173
references.citation: J Immunol. 2001 Sep 15;167(6):3316-23
references.pmid: 11544320
references.citation: Infect Immun. 2002 Mar;70(3):1097-105
references.pmid: 11854188
references.citation: Eur J Immunol. 2002 Mar;32(3):742-51
references.pmid: 11870618
references.citation: BioDrugs. 2002;16(1):19-35
references.pmid: 11908999
references.citation: Infect Immun. 2002 Jun;70(6):2741-51
references.pmid: 12010958
references.citation: J Immunol. 2002 Jun 1;168(11):5589-95
references.pmid: 12023355
references.citation: Infect Immun. 2002 Jul;70(7):3793-803
references.pmid: 12065523
references.citation: J Clin Invest. 2002 Jun;109(12):1519-26
references.pmid: 12070296
references.citation: J Exp Med. 2002 Jun 17;195(12):1565-73
references.pmid: 12070284
references.citation: Trends Immunol. 2002 Sep;23(9):445-9
references.pmid: 12200066
references.citation: Cancer Res. 2002 Sep 15;62(18):5260-6
references.pmid: 12234994
references.citation: J Immunol. 2002 Dec 1;169(11):6324-31
references.pmid: 12444139
references.citation: Infect Immun. 2003 Jan;71(1):117-25
references.pmid: 12496156
references.citation: Nat Rev Immunol. 2003 Feb;3(2):133-46
references.pmid: 12563297
references.citation: Annu Rev Immunol. 2003;21:685-711
references.pmid: 12615891
references.citation: Mol Microbiol. 2003 May;48(3):671-83
references.pmid: 12694613
references.citation: Immunity. 2003 Jun;18(6):813-23
references.pmid: 12818162
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8478-83
references.pmid: 12815105
references.citation: Cell Microbiol. 2003 Aug;5(8):493-500
references.pmid: 12864809
references.citation: Nat Rev Immunol. 2004 Jan;4(1):24-34
references.pmid: 14704765
references.citation: J Immunol. 2004 Feb 1;172(3):1727-34
references.pmid: 14734755
references.citation: J Immunol. 2004 Feb 15;172(4):2407-15
references.pmid: 14764711
references.citation: Am J Ophthalmol. 1979 Mar;87(3):350-3
references.pmid: 434096
references.citation: J Exp Med. 1985 Mar 1;161(3):526-46
references.pmid: 3871837
references.citation: Rev Infect Dis. 1985 Nov-Dec;7(6):717-25
references.pmid: 4070905
references.citation: Am J Trop Med Hyg. 1990 Apr;42(4):358-64
references.pmid: 2331044
references.citation: J Exp Med. 1990 Aug 1;172(2):631-40
references.pmid: 2373994
references.citation: J Exp Med. 1998 Sep 7;188(5):809-18
references.pmid: 9730883
references.citation: Nat Med. 1998 Dec;4(12):1409-15
references.pmid: 9846579
references.citation: Infect Immun. 1999 Apr;67(4):1763-9
references.pmid: 10085016
references.citation: Sex Transm Dis. 1978 Apr-Jun;5(2):73-7
references.pmid: 10328037
references.citation: J Exp Med. 1999 Jun 21;189(12):1931-8
references.pmid: 10377188
references.citation: J Leukoc Biol. 1999 Sep;66(3):462-70
references.pmid: 10496317
references.citation: Eur J Immunol. 2004 Apr;34(4):981-9
references.pmid: 15048708
references.citation: J Immunol. 2004 May 15;172(10):6281-9
references.pmid: 15128817
references.citation: Trends Immunol. 2004 Jul;25(7):353-9
references.pmid: 15207502
references.citation: J Exp Med. 2004 Jun 21;199(12):1607-18
references.pmid: 15197224
references.citation: J Immunol. 2004 Aug 1;173(3):1934-40
references.pmid: 15265927
references.citation: J Exp Med. 1992 Dec 1;176(6):1693-702
references.pmid: 1460426
references.citation: Infect Immun. 1996 Apr;64(4):1208-14
references.pmid: 8606080
references.citation: J Infect Dis. 1996 Apr;173(4):950-6
references.pmid: 8603976
references.citation: J Exp Med. 1997 Jan 20;185(2):317-28
references.pmid: 9016880
references.citation: Electrophoresis. 1997 Mar-Apr;18(3-4):563-7
references.pmid: 9150942
references.citation: Infect Immun. 1997 Aug;65(8):3386-90
references.pmid: 9234802
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: J Immunol. 1998 Feb 1;160(3):1297-303
references.pmid: 9570547
references.citation: J Exp Med. 2000 May 1;191(9):1525-34
references.pmid: 10790427